IDIOPATHIC PARKINSON DISEASE
Clinical trials for IDIOPATHIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for IDIOPATHIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow Parkinson's in genetically targeted patients
Disease control Recruiting nowThis Phase 2 trial tests an oral drug called NEU-411 in 150 adults aged 40-80 with early Parkinson's disease who have a specific genetic marker (LRRK2-driven). The study is double-blind and placebo-controlled, meaning neither patients nor doctors know who gets the real drug. Rese…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New turkish questionnaire aims to better measure Parkinson's movement side effects
Knowledge-focused Recruiting nowThis study is translating a questionnaire called the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and checking if it works well for Turkish-speaking patients. The questionnaire measures how involuntary movements (dyskinesia) affect daily life. Researchers will enro…
Matched conditions: IDIOPATHIC PARKINSON DISEASE
Sponsor: Izmir Bakircay University • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:52 UTC